Tumor suppression functions of Tid1 rely on degradation of ErbB2 in breast cancer [42], and attenuation of EGFR/Akt/Erk signaling in HNSCC and in NSCLC [18,20]. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.